PT Bundamedik TbkISX:BMHS -1.65%61 ROA % is 0.01% as of Mar. 2026, which is 99% below its 10-year median of 0.96. GuruFocus rates ISX:BMHS with a GF Score™ of 61/100 and a GF Value™ of Rp304.24 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 683 Healthcare Providers & Services companies, PT Bundamedik Tbk ranks worse than 61.49% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. PT Bundamedik Tbk's annualizedNet Income for the quarter that ended in Mar. 2026 was Rp263 Mil.
PT Bundamedik Tbk's average Total Assets over the quarter that ended in Mar. 2026 was Rp4,029,669 Mil. Therefore, PT Bundamedik Tbk's annualized ROA % for the quarter that ended in Mar. 2026 was 0.01%.
The historical rank and industry rank for PT Bundamedik Tbk's ROA % or its related term are showing as below:
ISX:BMHS'
s ROA % Range Over the Past 10 Years
Min: 0.25 Med: 0.96 Max: 8.48
Current: 0.25
During the past 8 years, PT Bundamedik Tbk's highest ROA % was 8.48%. The lowest was 0.25%. And the median was 0.96%.
ISX:BMHS's ROA % is ranked worse than 61.49% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.77
vs ISX:BMHS: 0.25
PT Bundamedik Tbk (ISX:BMHS) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
PT Bundamedik Tbk ROA % Related Terms
PT Bundamedik Tbk ROA % Historical Data
* Premium members only.
The historical data trend for PT Bundamedik Tbk's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, PT Bundamedik Tbk's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Bundamedik Tbk ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Bundamedik Tbk's ROA % distribution charts can be found below:
* The bar in red indicates where PT Bundamedik Tbk's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
PT Bundamedik Tbk (ISX:BMHS) has a ROA % of 0.01% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on PT Bundamedik Tbk and its competitors. This is 99% below median its historical median of 0.96. Over the past decade, PT Bundamedik Tbk's ROA % has ranged from 0.25 to 8.48. According to the industry distribution chart, PT Bundamedik Tbk ranks #420 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 61.5%.
Is PT Bundamedik Tbk's ROA % too high?
PT Bundamedik Tbk's current ROA % of 0.01% is 99% below median its 10-year median of 0.96. Over the past 10 years, this metric has ranged from a low of 0.25 to a high of 8.48. The Healthcare Providers & Services industry median ROA % is 1.77. PT Bundamedik Tbk's value of 0.01% is 99.4% below this industry median. Based on the distribution chart, PT Bundamedik Tbk ranks #420 out of 683 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PT Bundamedik Tbk has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Bundamedik Tbk's ROA % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Bundamedik Tbk ranks #420 out of 683 companies for ROA %. This places PT Bundamedik Tbk in the lower half of its industry. The industry median ROA % is 1.77. PT Bundamedik Tbk's value of 0.01% is 99.4% below this benchmark. Historically, PT Bundamedik Tbk's own ROA % has ranged from 0.25 to 8.48 over the past decade. While the company's 10-year median is 0.96 vs. the industry median of 1.77, PT Bundamedik Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.77, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Bundamedik Tbk's current ROA % of 0.01% is 99.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on PT Bundamedik Tbk and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Bundamedik Tbk's current ROA % is 0.01%, which is 99% below median its own 10-year median of 0.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Bundamedik Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Bundamedik Tbk (ISX:BMHS) is currently considered Possible Value Trap. The stock's GF Value™ is Rp304.24, compared to a current price of Rp179.00 — trading 41.2% below its estimated fair value. The current ROA % is 0.01%, which is 99% below median its 10-year median of 0.96 and 99.4% below the Healthcare Providers & Services industry median of 1.77. PT Bundamedik Tbk's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For PT Bundamedik Tbk (ISX:BMHS), the current ROA % is 0.01% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Bundamedik Tbk (ISX:BMHS) Overvalued in 2026?
Based on GuruFocus' analysis, PT Bundamedik Tbk stock appears to be undervalued.
The current stock price of Rp179.00 is trading 41.2% below its estimated GF Value™ of Rp304.24.
GuruFocus considers PT Bundamedik Tbk to be Possible Value Trap.
Key valuation signals for ISX:BMHS:
ROA %: 0.01% (99% below median its 10-year median of 0.96)
GF Value™: Rp304.24 vs. price of Rp179.00 (41.2% below fair value)
Industry Position: 99.4% below the Healthcare Providers & Services median (#420 of 683)
No single metric tells the full story. See the ISX:BMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Bundamedik Tbk is a healthcare service provider. The Company carries out its main business activities through private hospital activities. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.
61GF Score
Get the complete analysis for ISX:BMHS
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:BMHS has been successfully added to your 
